Recursion Pharmaceuticals Summit Therapeutics: 2026 Insight
Two biotech contenders, Recursion Pharmaceuticals and Summit Therapeutics, face off in a year of uncertainty and oppo...
Why economic indicators matter to investors: indicators help assess health, predict trends, and guide decisions, improving timing and risk management.
27,651 articlesTwo biotech contenders, Recursion Pharmaceuticals and Summit Therapeutics, face off in a year of uncertainty and oppo...
A high-earning investor can leverage oil well tax rules to dramatically reduce first-year tax bills, even as energy m...
Amazon stock has cooled after a strong run, but bulls argue AI investments, AWS momentum, and ad growth could fuel a ...
Hims & Hers Health shares surged in premarket trading after reports they ended a dispute with Novo Nordisk by forging...
Microsoft shares fell Tuesday as investors reassessed the cost of OpenAI bets and growing capital needs, even after a...
A Colorado resident was drawn into a high-pressure sales pitch for a $1 million fixed indexed annuity, featuring a ph...
AMD posts robust data-center growth and free cash flow gains, while Intel sticks to its turnaround plan with heavy fo...
Six months after a December 2025 spotlight, Vanguard’s overlooked Monthly Income ETF VWOB still delivers reliable mon...
Comcast weighs splitting NBCUniversal from its cable and broadband unit to unlock value. History shows media spinoffs...
SK Hynix kicked off trading on Wall Street with a double-digit rally, marking the largest U.S. IPO by a foreign compa...
A Trump-linked crypto issuer reports $1.2 billion in revenue from a tokenized resort-debt deal, highlighting a new pa...
Oracle leads data center stocks this week as AI cloud momentum outpaces rivals CoreWeave and Applied Digital in a vol...